Paper32434945
DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Yu J and 53 others. Science, 2020. Cited by 864 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Papers, record 32434945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32434945
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics30
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Betacoronavirus | Major topic |
| Coronavirus Infections | Major topic |
| Pandemics | Major topic |
| Pneumonia, Viral | Major topic |
| Spike Glycoprotein, Coronavirus | Major topic |
| Vaccines, DNA | Major topic |
| Viral Vaccines | Major topic |
| Adjuvants, Immunologic | |
| Animals | |
| Antibodies, Neutralizing | |
| Antibodies, Viral | |
| Bronchoalveolar Lavage Fluid | |
| COVID-19 | |
| COVID-19 Vaccines | |
| Disease Models, Animal | |
| Female | |
| Humans | |
| Immunity, Cellular | |
| Immunity, Humoral | |
| Immunization, Secondary | |
| Immunogenicity, Vaccine | |
| Immunologic Memory | |
| Macaca mulatta | |
| Male | |
| Mutant Proteins | |
| Nasal Mucosa | |
| Protein Domains | |
| SARS-CoV-2 | |
| Vaccination | |
| Viral Load |
Source PubMed
Grants16
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 AI007387 | NIAID NIH HHS | United States | T32AI007387 | PubMed and NIH | NIH RePORTER |
| R01 AI110700 | NIAID NIH HHS | United States | R01AI110700 | PubMed and NIH | NIH RePORTER |
| T32 AI007151 | NIAID NIH HHS | United States | T32AI007151 | PubMed and NIH | NIH RePORTER |
| R01 AI139538 | NIAID NIH HHS | United States | R01AI139538 | PubMed and NIH | NIH RePORTER |
| R01 AI108197 | NIAID NIH HHS | United States | R01AI108197 | PubMed and NIH | NIH RePORTER |
| UM1 AI126603 | NIAID NIH HHS | United States | UM1AI126603 | PubMed and NIH | NIH RePORTER |
| R01 AI147884 | NIAID NIH HHS | United States | R01AI147884 | PubMed | NIH RePORTER |
| R01 AI146779 | NIAID NIH HHS | United States | R01AI146779 | PubMed and NIH | NIH RePORTER |
| R01 AI121394 | NIAID NIH HHS | United States | R01AI121394 | PubMed and NIH | NIH RePORTER |
| U01 AI149644 | NIAID NIH HHS | United States | U01AI149644 | PubMed and NIH | NIH RePORTER |
| R01 OD024917 | NIH HHS | United States | R01OD024917 | PubMed and NIH | NIH RePORTER |
| UM1 AI124377 | NIAID NIH HHS | United States | UM1AI124377 | PubMed and NIH | NIH RePORTER |
| U19 AI100625 | NIAID NIH HHS | United States | U19AI100625 | PubMed and NIH | NIH RePORTER |
| R01 AI129797 | NIAID NIH HHS | United States | R01AI129797 | PubMed and NIH | NIH RePORTER |
| R01 AI132178 | NIAID NIH HHS | United States | R01AI132178 | PubMed and NIH | NIH RePORTER |
| U19 AI128751 | NIAID NIH HHS | United States | U19AI128751 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04944095 | Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations | Background |
Source ClinicalTrials.gov
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,995,857 | Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31995857 | PubMed |
| 2 | 31,978,945 | A Novel Coronavirus from Patients with Pneumonia in China, 2019. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31978945 | PubMed |
| 3 | 14,569,023 | Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14569023 | PubMed |
| 4 | 29,246,504 | A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization. | Antiviral Res | 2018 | https://conductscience.org/library/papers/29246504 | PubMed |
| 5 | 32,385,100 | Rapid COVID-19 vaccine development. | Science | 2020 | https://conductscience.org/library/papers/32385100 | PubMed |
| 6 | 15,024,391 | A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. | Nature | 2004 | https://conductscience.org/library/papers/15024391 | PubMed |
| 7 | 32,007,143 | Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. | Lancet | 2020 | https://conductscience.org/library/papers/32007143 | PubMed |
| 8 | 29,237,759 | Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. | Sci Transl Med | 2017 | https://conductscience.org/library/papers/29237759 | PubMed |
| 9 | 26,544,943 | Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology. | Cell | 2015 | https://conductscience.org/library/papers/26544943 | PubMed |
| 10 | 18,824,060 | A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. | Vaccine | 2008 | https://conductscience.org/library/papers/18824060 | PubMed |
| 11 | 32,015,508 | A new coronavirus associated with human respiratory disease in China. | Nature | 2020 | https://conductscience.org/library/papers/32015508 | PubMed |
| 12 | 31,986,261 | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. | Lancet | 2020 | https://conductscience.org/library/papers/31986261 | PubMed |
| 13 | 32,015,507 | A pneumonia outbreak associated with a new coronavirus of probable bat origin. | Nature | 2020 | https://conductscience.org/library/papers/32015507 | PubMed |
| 14 | 32,075,877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 15 | 28,807,998 | Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28807998 | PubMed |
| 16 | 17,559,989 | Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques. | Vaccine | 2007 | https://conductscience.org/library/papers/17559989 | PubMed |
| 17 | 32,376,603 | Development of an inactivated vaccine candidate for SARS-CoV-2. | Science | 2020 | https://conductscience.org/library/papers/32376603 | PubMed |
| 18 | 15,837,221 | Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. | Vaccine | 2005 | https://conductscience.org/library/papers/15837221 | PubMed |
| 19 | 30,830,861 | Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. | JCI Insight | 2019 | https://conductscience.org/library/papers/30830861 | PubMed |
| 20 | 32,235,945 | Virological assessment of hospitalized patients with COVID-2019. | Nature | 2020 | https://conductscience.org/library/papers/32235945 | PubMed |
Cited by663
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 864 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,903,854 | Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platforms. | Hlife | 2024 | https://conductscience.org/library/papers/42903854 | PubMed |
| 42,842,678 | Exposure route, not dose, is the primary driver of infection patterns for a respiratory virus. | Sci Adv | 2026 | https://conductscience.org/library/papers/42842678 | PubMed |
| 42,307,560 | The Association of Primate Veterinarians and the European Primate Veterinarians Position Statement on the Value of Nonhuman Primates in Research. | J Am Assoc Lab Anim Sci | 2026 | https://conductscience.org/library/papers/42307560 | PubMed |
| 42,288,524 | Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2. | Sci Rep | 2026 | https://conductscience.org/library/papers/42288524 | PubMed |
| 42,118,760 | Trends of laboratory nonhuman primate licensing in China between 2020 and 2024: A national database analysis. | PLoS One | 2026 | https://conductscience.org/library/papers/42118760 | PubMed |
| 42,063,787 | A phase 1, single-center, randomized, dose finding study to evaluate the safety, tolerability, and immunogenicity of a prophylactic COVID-19 pDNA vaccine after single ascending doses in healthy adults. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42063787 | PubMed |
| 42,000,737 | Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/42000737 | PubMed |
| 41,867,858 | Exposure route drives SARS-CoV-2 infection patterns in non-human primates. | bioRxiv | 2026 | https://conductscience.org/library/papers/41867858 | PubMed |
| 41,862,531 | Vaccine-derived T-cell responses are insufficient to generate protective immunity to SARS-CoV-2. | Sci Rep | 2026 | https://conductscience.org/library/papers/41862531 | PubMed |
| 41,839,978 | Evaluating southern pigtail macaques as an immunological model for human antibody responses. | Sci Rep | 2026 | https://conductscience.org/library/papers/41839978 | PubMed |
| 41,441,723 | Immunogenicity of Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Versus Non-Adjuvanted SARS-CoV-2 Spike Booster Vaccines in Young and Aged Balb/c Mice. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41441723 | PubMed |
| 41,383,761 | Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like Betacoronaviruses. | bioRxiv | 2025 | https://conductscience.org/library/papers/41383761 | PubMed |
| 41,295,541 | Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295541 | PubMed |
| 41,136,184 | Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort. | Gut | 2026 | https://conductscience.org/library/papers/41136184 | PubMed |
| 40,957,415 | Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines. | Cell | 2025 | https://conductscience.org/library/papers/40957415 | PubMed |
| 40,841,372 | Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection. | Nat Commun | 2025 | https://conductscience.org/library/papers/40841372 | PubMed |
| 40,740,485 | SARS-CoV-2 vaccines elicit differential Fc effector functions. | iScience | 2025 | https://conductscience.org/library/papers/40740485 | PubMed |
| 40,561,578 | When less is statistically Equivalent: Lobe-Specific optimization of histopathological assessment in SARS-CoV-2 pneumonia. | Comput Biol Med | 2025 | https://conductscience.org/library/papers/40561578 | PubMed |
| 40,477,216 | SARS-CoV-2 virus: Vaccines in development. | Fundam Res | 2021 | https://conductscience.org/library/papers/40477216 | PubMed |
| 40,477,151 | Current progress and challenges in the design and development of a successful COVID-19 vaccine. | Fundam Res | 2021 | https://conductscience.org/library/papers/40477151 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL4 | 6,351 | PubTator's text mining | https://conductscience.org/library/genes/6351 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FURIN | 5,045 | PubTator's text mining | https://conductscience.org/library/genes/5045 | NCBI Gene |
| IFNG | 3,458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL4 | 3,565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| LAMP1 | 3,916 | PubTator's text mining | https://conductscience.org/library/genes/3916 | NCBI Gene |
| SPINK5 | 11,005 | PubTator's text mining | https://conductscience.org/library/genes/11005 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32434945
GET https://conductscience.org/api/papers/v1/32434945/authors?page=2